FSMAX
Price
$101.54
Change
-$1.22 (-1.19%)
Updated
Oct 7 closing price
Net Assets
41.44B
TMITX
Price
$11.26
Change
-$0.06 (-0.53%)
Updated
Oct 7 closing price
Net Assets
147.3M
Interact to see
Advertisement

FSMAX vs TMITX

Header iconFSMAX vs TMITX Comparison
Open Charts FSMAX vs TMITXBanner chart's image
Fidelity Extended Market Index
Price$101.54
Change-$1.22 (-1.19%)
VolumeN/A
Net Assets41.44B
Transamerica Mid Cap Growth I3
Price$11.26
Change-$0.06 (-0.53%)
VolumeN/A
Net Assets147.3M
FSMAX vs TMITX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. TMITX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and TMITX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41.4B vs. TMITX (147M). FSMAX pays higher dividends than TMITX: FSMAX (0.44) vs TMITX (0.00). FSMAX was incepted earlier than TMITX: FSMAX (14 years) vs TMITX (12 years). TMITX (0.79) is less costly to investors than FSMAX (0.04). TMITX is a more actively managed with annual turnover of: 106.00 vs. FSMAX (9.00). FSMAX (0) and TMITX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 19.58 vs. TMITX (11.31). FSMAX return over 5 years is better than : 53.17 vs. TMITX (-11.70).
FSMAXTMITXFSMAX / TMITX
Total Expense Ratio0.040.794%
Annual Report Gross Expense Ratio0.040.794%
Fund Existence14 years12 years-
Gain YTD13.07211.527113%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets41.4B147M28,163%
Annual Yield % from dividends0.440.00-
Returns for 1 year19.5811.31173%
Returns for 3 years70.0267.70103%
Returns for 5 years53.17-11.70-454%
Returns for 10 years107.23-1.34-8,024%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYLSX91.79N/A
N/A
Rydex Leisure A
RLCAX9.33N/A
N/A
Columbia Disciplined Value A
HLMGX37.80N/A
N/A
Harding Loevner Global Equity Advisor
SHSKX67.99N/A
N/A
BlackRock Health Sciences Opps K
OBSIX28.95N/A
N/A
Oberweis Small-Cap Opportunities Instl